Interesting Facts

Updated: Q&A on Trump’s COVID-19 Diagnosis

Share this:

Editor’s Note: We will proceed to replace this story as wanted.

On Oct. 2, President Donald Trump revealed that he and First Lady Melania Trump had examined optimistic for COVID-19. Here we reply widespread questions in regards to the dangers of the illness, remedies out there and the shortcomings of testing.

What will we find out about Trump’s danger of growing severe COVID-19?

Without understanding all of Trump’s medical historical past, it’s tough to know the way harmful his SARS-CoV-2 an infection could be. On the morning of Oct. 2, information shops reported — and White House Chief of Staff Mark Meadows confirmed — that the president was experiencing solely gentle signs. 

White House Press Secretary Kayleigh McEnany reiterated the signs had been “mild” within the afternoon, although Trump was taken to Walter Reed National Military Medical Center and could be “working from the presidential offices at Walter Reed for the next few days,” McEnany mentioned. 

On Oct. 3, a supply acquainted with the president’s health, who was later revealed to be Meadows, instructed that Trump’s situation was extra severe. “The president’s vitals over the last 24 hours were very concerning and the next 48 hours will be critical in terms of his care,” Meadows informed a White House pool reporter in a pool report issued at about midday. “We’re still not on a clear path to a full recovery.”

The president’s physician, Navy doctor Sean P. Conley, gave a extra upbeat evaluation at a press convention Oct. 3, describing the president as being fever-free and “doing great.”

During a press convention on Oct. 4, Trump’s physicians emphasised that he continued “to improve” however mentioned that the president had been given the steroid dexamethasone, which is not beneficial until sufferers require supplemental oxygen. Trump additionally had skilled two bouts of low oxygen ranges, they mentioned, and had been given oxygen at the very least as soon as, on Oct. 2.

Trump tweeted on Oct. 5 that he would depart Walter Reed hospital that night at 6:30.

At 74 years previous, Trump is at larger danger of growing a extra extreme case of COVID-19 than youthful folks. Figures from the Centers for Disease Control and Prevention, primarily based on knowledge out there by way of Aug. 6, present that folks ages 65 to 74 are 5 occasions as probably as 18- to 29-year-olds to be hospitalized and 90 occasions extra more likely to die.

Other CDC knowledge present that for the month of August, 6.5% of individuals between the ages of 70 and 79 who had been identified with COVID-19 died, and 18% had been hospitalized, though some knowledge on loss of life or hospitalization is lacking or unknown.

Trump can be a person — and males have constantly had worse outcomes, on common, than females — and his final bodily confirmed he was mildly overweight, with a physique mass index of 30.5 (30 is taken into account overweight). 

According to the CDC, weight problems will increase the danger of a extreme sickness from COVID-19 and should triple the danger of hospitalization. It’s not totally understood why that is, however carrying an excessive amount of further weight has been linked to impaired immune operate and fats tissue may push up on the diaphragm, making it tougher to breathe.

Most folks, nevertheless — even these with danger components — don’t get significantly sick, so the president’s probabilities for a gentle an infection should still be good. He can be not recognized to have lots of the different danger components for severe illness, akin to diabetes or kidney illness, and is more likely to obtain the absolute best medical care. 

Scientists are simply starting to grasp why sure folks fare so poorly with a SARS-CoV-2 an infection whereas others by no means develop signs or solely get mildly sick. Recent analysis means that one distinction, which can apply to about 14% of extreme circumstances, is that some folks don’t produce sufficient sort I interferons early in an infection. The proteins are key gamers in preventing off viruses and assist kick off a strong immune response, though an excessive amount of of them in a while may very well be detrimental.

In some circumstances, a poor interferon response could outcome from folks having antibodies that inappropriately goal and cripple the interferon, whereas others could also be as a result of defective genes. The offending antibodies are a lot extra widespread in males. Older folks can also have defects in how their our bodies mount such a early, or innate, immune response.

Other analysis additionally signifies that older individuals are much less more likely to produce a ample T cell response to SARS-CoV-2. T cells are a part of the physique’s later, extra particular immune response, and help with producing antibodies and in addition kill off contaminated cells. With fewer of those cells, older sufferers don’t create a coordinated response to struggle off the virus and usually tend to have poor outcomes.

What do we all know in regards to the president’s health?

The president’s physician supplied the most recent replace on Trump’s health on June 3. He mentioned the president “remains healthy.” Trump was 6’3″ and weighed 244 kilos; his ldl cholesterol was 167, decrease than the earlier bodily. (A studying under 200 is taken into account fascinating.) His blood strain was regular: 121/79.

About six months previous to that report, in November 2019, Trump made an unannounced go to to Walter Reed National Military Medical Center, which he and his workers later mentioned was to conduct a part of his annual bodily. Conley’s memo mentioned his abstract included info each from November and an April examination Conley carried out.

The president was taking rosuvastatin, a medication for ldl cholesterol, finasteride, used to deal with an enlarged prostate or hair loss, and aspirin day by day.

In 2018, then-White House doctor Dr. Ronny Jackson revealed Trump underwent a coronary calcium CT scan that confirmed the presence of plaque. Dr. Rachel Bond of Lenox Hill Hospital in New York informed CNN the rating of 133 on the check signifies “he certainly has coronary artery disease because calcium is present. But this is also common for someone his gender, race and age.”

Who within the White House has examined optimistic over the course of the pandemic?

Before Trump and First Lady Melania Trump revealed they’d examined optimistic for COVID-19, Hope Hicks, counselor to the president, examined optimistic, as of Oct. 1.

CNN reported that three journalists who work on the White House, in addition to a White House staffer within the press space of the West Wing, had examined optimistic on Oct. 2.

Nick Luna, a private assistant to the president, examined optimistic, in accordance with Oct. Three press studies. White House Press Secretary Kayleigh McEnany examined optimistic on Oct. 5, she mentioned on Twitter. CNN reported that day that two deputies of McEnany — Chad Gilmartin and Karoline Leavitt — additionally examined optimistic.

Stephen Miller, a senior adviser to Trump, examined optimistic on Oct. 6.

Before these circumstances, National Security Adviser Robert O’Brien examined optimistic in late July; marketing campaign fundraiser Kimberly Guilfoyle, the girlfriend of Donald Trump Jr., examined optimistic the July Four weekend; and Katie Miller, Pence’s spokesperson, examined optimistic in early May.

Others testing optimistic for COVID-19 embody an unidentified White House staffer, unidentified member of Pence’s workers, a White House valet, former appearing chair of the White House Council of Economic Advisers Tomas Philipson, a Marine with the unit working Marine One, and a cafeteria employee within the Eisenhower Executive Office Building.

Who has examined optimistic after attending presidential or marketing campaign occasions?

In early October, others have examined optimistic for COVID-19 who don’t work within the White House advanced, however have had contact with Trump and administration staffers by way of their work for his marketing campaign or by attending occasions, akin to a Sept. 26 Rose Garden occasion introducing Trump’s Supreme Court nominee, Amy Coney Barrett.

Kellyanne Conway, a former White House counselor, and former New Jersey Gov. Chris Christie — each of whom assisted the president in debate preparations and attended the Sept. 26 occasion — introduced on Twitter they’d examined optimistic. Four others who attended the Sept. 26 occasion have COVID-19: Sens. Mike Lee and Thom Tillis, Rev. John Jenkins, president of the University of Notre Dame, and Pastor Greg Laurie.

Trump Campaign Manager Bill Stepien examined optimistic.

Sen. Ron Johnson additionally examined optimistic, he introduced on Oct. 3, although he didn’t attend the Sept. 26 occasion on the White House. Republican National Committee Chairwoman Ronna McDaniel additionally has COVID-19; she final was across the president at a Sept. 25 occasion, in accordance with the New York Times.

The metropolis of Cleveland introduced that it knew of 11 optimistic circumstances “stemming from pre-debate planning and set-up” for the Sept. 29 presidential debate. The metropolis didn’t establish these people, solely saying “the majority” had been “out of state residents.”

Before the latest spate of infections, six members of the Trump marketing campaign advance staff examined optimistic previous to a Trump marketing campaign rally on June 20, and two extra staffers examined optimistic afterward.

What COVID-19 remedies can be found and the way efficient are they?

Despite Trump’s repeated insistence that nice progress has been made on COVID-19 therapy, there are no Food and Drug Administration-approved medicine for COVID-19 and just one medicine has been proven in a medical trial to enhance mortality.

As we defined earlier than, when Trump attributed an 85% decline within the case fatality price since April to “pioneering therapies,” most therapy consists of supportive care. And as University of Pennsylvania infectious illness fellow Dr. Aaron Richterman informed us in an e-mail, “We have a long way to go in our treatment.”

In a medical trial, the antiviral drug remdesivir shortened the time to restoration amongst hospitalized sufferers to a median of 11 days from 15 days. The medicine acquired an emergency use authorization, or EUA, from the FDA, however that’s restricted to make use of amongst hospitalized sufferers.

Convalescent plasma could also be efficient, however the jury remains to be out on that — and for now, the National Institutes of Health therapy tips don’t take into account it a normal of care and neither suggest for nor in opposition to its use. Like remdesivir, it too is just out there beneath its EUA to those that are hospitalized with COVID-19.

The steroid dexamethasone is the one medicine to have demonstrated a survival profit in COVID-19 sufferers. As a drug beforehand authorised for different makes use of, dexamethasone may be given to any affected person off-label, however knowledge point out the drug is just efficient for individuals who want supplemental oxygen — and could hurt these with much less extreme circumstances. Accordingly, the NIH tips don’t suggest dexamethasone in sufferers who don’t require supplemental oxygen.

There is hope {that a} new line of medicine generally known as monoclonal antibodies will show to be efficient and will function a “bridge” till the arrival of a vaccine. These medicine are comparable in idea to convalescent plasma, however are fabricated from optimized artificial antibodies that could be safer and stronger than the antibodies remoted from human plasma.

Although nonetheless being examined in medical trials, at the very least two corporations have introduced optimistic preliminary findings. 

On Sept. 16, pharma firm Eli Lilly launched preliminary knowledge from a section 2 trial of its SARS-CoV-2 neutralizing antibody that reported the remedy diminished the quantity of virus in outpatients and in addition minimize the speed of hospitalization.

On Sept. 29, biotech firm Regeneron equally introduced that its antibody cocktail diminished viral ranges and diminished signs amongst non-hospitalized COVID-19 sufferers.

Neither firm, nevertheless, has printed its knowledge but and the outcomes shouldn’t be considered as definitive.

Trump’s doctor mentioned within the afternoon of Oct. 2 that the president had acquired an eight gram dose of Regeneron’s antibody cocktail “as a precautionary measure.” According to Regeneron’s press launch, that’s the “high” dose the corporate is presently testing.

On the night of Oct. 2, Trump began on a five-day course of remdesivir and on Oct. Three was given his first dose of dexamethasone.

What are the testing procedures on the White House?

On April 3, the White House introduced that anybody in “close proximity” to Trump and Vice President Mike Pence could be examined.

On July 21, White House Press Secretary Kayleigh McEnany mentioned the president himself is examined “multiple times a day,” however Trump contradicted that hours later. He mentioned: “I do take probably, on average, a test every two days, three days. And I don’t know of any time I’ve taken two tests in one day, but I could see that happening.”

On Aug. 3, Politico reported that government department staff had been informed they might be topic to random testing. A White House spokesperson informed Politico: “As part of our ongoing efforts to protect the health and safety of the entire White House Complex, randomized testing of Executive Office of the President staff, which has been ongoing for several months, will become mandatory rather than voluntary.”

News studies and Trump’s former marketing campaign supervisor Corey Lewandowski have indicated the White House makes use of an Abbott labs check, which might present leads to 15 minutes. Lewandowski mentioned in an interview on the “Today” present on Oct. 2 that he acquired such a quick-results check twice this week when seeing Trump.

Why didn’t the White House’s testing routine stop the president from changing into contaminated?

Rigorous testing procedures may also help establish circumstances and scale back the danger of an outbreak, however can’t make sure that nobody will get contaminated.

As Harvard epidemiologist Michael Mina defined on Twitter, frequent testing labored within the sense that the transmission chain “is severed.” But, he added, checks are “not prophylactics.”

“They alone cannot stop the test taker from getting infected. But can serve to stop onward spread from the tester,” he wrote. “To stop from getting infected, masks/social distancing are needed.”

It’s additionally necessary to acknowledge the inherent limitations in diagnostic checks. Even if somebody checks damaging, that doesn’t essentially imply that an individual isn’t contaminated — solely that the check didn’t detect the presence of the virus at that particular time.

Given that it could actually take a number of days and even longer for the virus to turn out to be detectable, a damaging outcome means somebody nonetheless may very well be infectious and different public health measures ought to nonetheless be taken.

The White House was reportedly utilizing Abbot’s ID NOW check as a speedy check for screening workers. The check is a molecular check that appears for the viral genome in a nasal swab pattern, however is quicker and fewer delicate than the usual PCR checks.

Mina mentioned in an Oct. 2 press name that the check was excellent — maybe one of the best speedy check out there. But no check is ideal, and the check shouldn’t be truly designed for use the best way the White House deployed it. 

The FDA’s EUA was revised in mid-September to specify that testing is meant to be “from individuals who are suspected of COVID-19 by their health care provider within the first seven days of the onset of symptoms.” In different phrases, the check is supposed for individuals who have signs, not for surveillance.

What is the standing of a COVID-19 vaccine?

There are presently 4 corporations working section Three trials of a coronavirus vaccine within the U.S. One or extra vaccines could also be out there by the tip of the yr or by early 2021 to pick teams, assuming the trials go nicely and the pictures are discovered to be secure and efficient. Members of the overall inhabitants who should not prioritized for vaccination, nevertheless, are not anticipated to have the ability to obtain a vaccine till later in 2021.

The main firm, when it comes to timing, is Pfizer/BioNTech, which has enrolled 35,469 individuals in its trial and given 24,298 volunteers each doses of its mRNA vaccine as of Sept. 28. It is the one firm that also claims to have the ability to have a solution on whether or not its vaccine is secure and efficient previous to Nov. 3.

Moderna’s section Three trial of its mRNA vaccine has enrolled 27,232 individuals as of Sept. 25, 15,454 of whom have acquired two doses. Moderna’s CEO mentioned on Sept. 30 that the earliest he anticipated the corporate to be capable to file an EUA with the FDA is Nov. 25, with a wider approval coming maybe in March 2021. 

Oxford-AstraZeneca’s viral vector vaccine trial is nonetheless on pause within the U.S. pending an investigation right into a attainable extreme aspect impact in a volunteer within the U.Okay. 

Johnson & Johnson’s vaccine, which additionally makes use of a viral vector, albeit a special one, started section Three testing on Sept. 23. It is the one candidate of the 4 to require just one dose and to not want subzero temperatures.

Editor’s Note: Please take into account a donation to We don’t settle for promoting. We depend on grants and particular person donations from folks such as you. Credit card donations could also be made by way of our “Donate” web page. If you like to present by examine, ship to:, Annenberg Public Policy Center, 202 S. 36th St., Philadelphia, PA 19104.

This truth examine is accessible at IFCN’s 2020 US Elections FactChat #Chatbot on WhatsApp. Click right here for extra.

Source hyperlink

Comment here